Schedule 13G ownership disclosure

EUPRAXIA PHARMACEUTICALS INC

Common Shares · CUSIP: 29842P105

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MANCHESTER MANAGEMENT COMPANY, LLC

    Shares: 4,720,144.00 · Class: 8.8%

  • MANCHESTER MANAGEMENT PR, LLC

    Shares: 4,720,144.00 · Class: 8.8%

  • MANCHESTER EXPLORER, L.P

    Shares: 4,597,217.00 · Class: 8.6%

  • JAMES E. BESSER

    Shares: 4,858,437.00 · Class: 9.1%

  • MORGAN C. FRANK

    Shares: 4,904,523.00 · Class: 9.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-26-001077
Form type
SCHEDULE 13G/A
Filer
EUPRAXIA PHARMACEUTICALS INC.
CIK
CIK 1581178
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub